Ls. Yoshida et al., MUTATION AT HISTIDINE-338 OF GP91(PHOX) DEPLETES FAD AND AFFECTS EXPRESSION OF CYTOCHROME B(558) OF THE HUMAN NADPH OXIDASE, The Journal of biological chemistry, 273(43), 1998, pp. 27879-27886
Defective NADPH oxidase components prevent superoxide (O-2(radical ani
on)) generation, causing chronic granulomatous disease (CGD). X-linked
CGD patients have mutations in the gene encoding the gp91(phox) subun
it of cytochrome b(558) and usually lack gp91(phox) protein completely
(X91(0)). gp91(phox) is considered to be a flavocytochrome that conta
ins binding sites for NADPH, FAD, as well as heme. We here report a ra
re X-linked CGD patient whose neutrophils entirely failed to produce O
-2(radical anion), but presented a diminished expression of gp91(phox)
containing about one-third of the heme present in normal individuals
by Soret absorption. Translocation of cytosolic factors p67(phox) and
p47(phox) was normal. However, the FAD content in his neutrophil membr
anes was as low as that of X91(0) patients, suggesting complete deplet
ion of FAD in his gp91(phox). This was in agreement with the finding t
hat a single base substitution (C1024 to T) changed His-338 to Tyr in
gp91(phox) in a predicted FAD-binding domain of the flavocytochrome mo
del. The loss of FAD could not be corrected even after addition of rea
gent FAD or a FAD-rich dehydrogenase fraction isolated from normal neu
trophils to the patient's membranes, in a reconstitution in vitro with
normal cytosol. These results indicate that His-338 is a very critica
l residue for FAD incorporation into the NADPH oxidase system. This is
the first such mutation found in CGD.